FDA warns of possible increased risk of death with somatropin - MPR
Links shared publicly online about this topic.
- 636total visits
FDA warns of possible increased risk of death with somatropin - MPR
empr.com —
View full resource at empr.com
Tags: Prader-Willi Syndrome Medication, Turner Syndrome Medication, Growth Failure Medication, FDA, Genotropin, News, Mortality
Most Recently Shared on December 22, 2010 at 9:35 pm By:
MPR News: FDA warns of possible increased risk of death with somatropin: The FDA is informing consumers that res... http://bit.ly/i8OC2o
FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death
drugs.com — “FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death” View full resource at drugs.com
Most Recently Shared on August 6, 2011 at 12:11 am By:
FDA Alert - Ongoing Safety Review: Recombinant Human Growth Hormone (somatropin) - Possible Increased Risk of Death - http://bit.ly/rnFswC
FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death
drugs.com — “FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death” View full resource at drugs.com
Most Recently Shared on August 4, 2011 at 10:02 pm By:
Drugs and Devices OW OW Health
Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death: Au... http://bit.ly/oUI0Pg #FDA
FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death
drugs.com — “FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death” View full resource at drugs.com
Most Recently Shared on December 24, 2010 at 8:11 am By:
Drugs and Devices OW OW Health
Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death: Au... http://bit.ly/fjjfJK #FDA
FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death
drugs.com — “FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death” View full resource at drugs.com
Most Recently Shared on December 24, 2010 at 8:01 am By:
FDA Alert - Ongoing Safety Review: Recombinant Human Growth Hormone (somatropin) - Possible Increased Risk of Death - http://bit.ly/g0aO5x
FDA cautions about heart risk with Parkinson's drug Stalevo | Local news, sports, weather, blogs, opinion, crime, obituaries, business, directory, marketplace, education, high school, family, shopping, arts, entertainment, movies, books, cooking, auto, re
wenatcheeworld.com — “LOS ANGELES " The Food and Drug Administration on Friday cautioned that it is investigating the possibility that the combination Parkinson's drug Stalevo may increase the risk of heart attack, stroke and death in elderly patients who are taking it. The agency urged patients not to stop taking the drug, but warned them to let their physicians know if the patients have risk factors for cardiovascular disease. Stalevo, sold by Novartis, is a combination of three drugs: carbidopa, levodopa and entac” View full resource at wenatcheeworld.com
Most Recently Shared on August 23, 2010 at 5:10 pm By:
FDA cautions about heart risk with Parkinsons drug Stalevo: LOS ANGELES The Food and Drug Administration on Frida... http://bit.ly/cJusNT
Advertisement
